OncoLink at ASTRO 2001: Tuesday, November 6
Continuing OncoLink coverage from ASTRO 2001.
OncoLink at ASTRO 2001. Booth 2450.
A Phase II Trial of Subcutaneous Amifostine and Radiation Therapy in Patients with Head and Neck Cancer (WR-B060) A Phase III Trial Comparing Whole-Pelvic (WP) to Prostate Only (PO) Radiotherapy and Neoadjuvant to Adjuvant Total Androgen Suppression (TAS): Preliminary Analysis of RTOG 9413 A Prospective Study on Tumor Hypoxia Kinetics to Implement Hypoxic Imaging-Guided IMRT Cost-Utility Analysis of RTOG 90-03: Phase III Randomized Study Comparing Altered Fractionation to Standard Fractionation Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma COX Inhibitors Markedly enhance Tumor Radiosensitization of Cultured Human Cancer Cells under Acidic Microenvironment Eight Year Results in the Treatment of Keloids by HDR Brachytherapy Internet Utilization by Radiation Oncology Patients Locoregional Failure of Post-Mastectomy Patients Who Had 1-3 Positive Axillary Lymph Nodes without Adjuvant Radiotherapy Molecular Markers of Patient Outcome in Prostate Cancer Treated with Radiotherapy: Ki-67, Bcl-2, Bax, and Bcl-x One Year Follow-up Reveals No Difference in Quality of Life Between High Dose and Conventional Dose Radiation: A Quality of Life Assessment of RTOG 94-05 Patterns of Local Regional Failure in Head and Neck Cancer Treated with IMRT PET Response is the Most Powerful Predictor of Survival after Radical Radiotherapy/Chemoradiotherapy for Unresectable Non-Small Cell Lung Cancer Positron Emission Tomography after Three-Dimensional Conformal Radiation Preliminary Results of a Randomized Study of Tamoxifen Alone or Tamoxifen and Breast Radiation in Women over 50 Years of Age with T1/2 N0 Disease Selenium in the Treatment of Radiation-Associated Lymphedemas The Impact of Anemia on PSA Outcome following Radiation and Androgen Suppression Therapy in Patients with High-Risk Prostate Cancer Treatment of Acoustic Neuroma: Stereotactic Radiosurgery vs Microsurgery